[Pharmacological treatment of pathological increases in muscle tonus]

Your saved search

Your RSS Feed

. 1978 Feb 15;128(3):57-62.

[Article in German]

[Article in German]

H Reisner. Wien Med Wochenschr. 1978.

. 1978 Feb 15;128(3):57-62.

No abstract available

Similar articles

Baclofen for spasticity.
[No authors listed] [No authors listed] Drug Ther Bull. 1973 Aug 3;11(6):63-4. Drug Ther Bull. 1973. PMID: 4731234 No abstract available.
A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
Smolenski C, Muff S, Smolenski-Kautz S. Smolenski C, et al. Curr Med Res Opin. 1981;7(6):374-83. Curr Med Res Opin. 1981. PMID: 7016449 Clinical Trial.
Drug treatment of multiple sclerosis.
Rudick RA, Schiffer RB, Herndon RM. Rudick RA, et al. Semin Neurol. 1987 Jun;7(2):150-9. doi: 10.1055/s-2008-1041415. Semin Neurol. 1987. PMID: 2845549 Review. No abstract available.
Overview of MS spasticity.
Pozzilli C. Pozzilli C. Eur Neurol. 2014;71 Suppl 1:1-3. doi: 10.1159/000357739. Epub 2014 Jan 22. Eur Neurol. 2014. PMID: 24457845 No abstract available.
Intrathecal baclofen therapy for spastic hypertonia.
Ivanhoe CB, Tilton AH, Francisco GE. Ivanhoe CB, et al. Phys Med Rehabil Clin N Am. 2001 Nov;12(4):923-38, viii-ix. Phys Med Rehabil Clin N Am. 2001. PMID: 11727722 Review.

Anti-spasticity agents for multiple sclerosis.
Shakespeare DT, Young CA, Boggild M. Shakespeare DT, et al. Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. PMID: 11034714 Free PMC article. Updated.